GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » 3-Year Sharpe Ratio

ATR (AptarGroup) 3-Year Sharpe Ratio : 0.65 (As of Jun. 26, 2025)


View and export this data going back to 1993. Start your Free Trial

What is AptarGroup 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-06-26), AptarGroup's 3-Year Sharpe Ratio is 0.65.


Competitive Comparison of AptarGroup's 3-Year Sharpe Ratio

For the Medical Instruments & Supplies subindustry, AptarGroup's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup's 3-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where AptarGroup's 3-Year Sharpe Ratio falls into.


;
;

AptarGroup 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


AptarGroup  (NYSE:ATR) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


AptarGroup 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of AptarGroup's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Executives
Xiangwei Gong officer: President, Asia 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Marc Prieur officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Hedi Tlili officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Shiela Vinczeller officer: Chief Human Resource Officer 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Stephan B. Tanda director, officer: President and CEO C/O PATHEON N.V., HERENGRACHT 483, AMSTERDAM P7 1017 BT
Monnas Giovanna Kampouri director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey officer: EVP and General Counsel 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Gael Touya officer: Segment President 475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Robert Kuhn officer: EVP & CFO C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Sarah Js Glickman director 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades director 281 SUMMIT AVENUE, SUMMIT NJ 07901
Julie Xing director 265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Matthew L. Trerotola director 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Ralf K. Wunderlich director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014